FIELD: medicine. SUBSTANCE: method involves exposing iris projection to laser radiation having 0.488 mcm wavelength, 1 mW power for 2-8 min. Ascorbic acid and heparin are subconjunctivally administered before applying the treatment. Insufficient fibrinoresorption action being observed, urokinase is administered at a dose of 3000 MU. EFFECT: accelerated and reliable inflammation process arrest. 3 cl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR REVEALING NOT VISUALIZED FIBRINOUS EXUDATE IN THE MOISTURE OF THE FORWARD CHAMBER OF THE EYE | 2005 |
|
RU2297857C2 |
METHOD FOR TREATING THE CASES OF POSTOPERATIVE INFLAMMATORY COMPLICATIONS AFTER CATARACT EXTRACTION AND ARTIFICIAL EYE LENS IMPLANTATION | 2005 |
|
RU2290203C1 |
METHOD OF TREATMENT OF UVEITIS | 0 |
|
SU1524886A1 |
METHOD FOR TREATING RETINA AND OPTIC NERVE DISEASES OF DYSTROPHIC GENESIS | 2002 |
|
RU2199989C1 |
METHOD OF CARRYING OUT YAG LASER IRIDECTOMY | 2017 |
|
RU2661558C1 |
METHOD OF PREDICTING DEGREE OF RISK OF INTRAOCULAR INFECTION AT OPEN TRAUMA OF EYE | 2008 |
|
RU2350255C1 |
METHOD FOR TREATING AN ACUTE ATTACK OF ANGLE-CLOSURE GLAUCOMA | 2021 |
|
RU2773802C1 |
METHOD FOR PERFORMING CAPSULORHEXIS IN RIGID PUPIL ACCOMPANYING PHAKOEMULSIFICATION IN PATIENTS WITH GLAUCOMA | 2013 |
|
RU2535779C1 |
METHOD FOR TREATING UVEITIS IN CHILDREN | 1999 |
|
RU2185193C2 |
METHOD FOR DETERMINING THE NEED FOR PRESCRIBING ANTIBIOTIC THERAPY FOR UVEITIS | 2021 |
|
RU2762492C1 |
Authors
Dates
2002-11-10—Published
2001-09-07—Filed